Physician and pharmaceutical industry. II. Postmarketing surveillance
Offerhaus, L.
Nederlands Tijdschrift Voor Geneeskunde 136(1): 36-41
1992
ISSN/ISBN: 0028-2162 PMID: 1728761 Document Number: 389678
Document emailed within 1 workday
Related Documents
Patterson, C. 1999: Postmarketing surveillance study of a non-chlorofluorocarbon inhaler Postmarketing surveillance studies remain unethical Bmj 318(7186): 810-811Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25
Fletcher, A.P. 1995: The demise of postmarketing surveillance Adverse Drug Reactions and Toxicological Reviews 14(1): 7-9
Goldman, S.A. 2002: Postmarketing surveillance and black box warnings JAMA 288(8): 956
Fisher, S.; Bryant, S.G.; Solovitz, B.L.; Kluge, R.M. 1987: A patient-initiated postmarketing surveillance system Psychopharmacology Bulletin 23(3): 400-404
Duclos, P. 1994: Postmarketing surveillance of secondary effects of vaccines Revue d'Epidemiologie et de Sante Publique 42(5): 425-433
Cao, W.; Li, L.; Hu, Y.; Zhan, S.; Li, X.; Li, P.; Wu, T.; Li, J.; Wang, T. 2000: Evaluation on the effect of Benazepril for hypertension through postmarketing surveillance Zhonghua Liu Xing Bing Xue Za Zhi 21(3): 190-193
Gut, J.P.; Auriche, M.; Spriet-Pourra, C.; Juillet, Y. 1985: Critical study of methods of postmarketing drug surveillance Therapie 40(5): 313-319
Fries, J.F.; Bloch, D.A.; Segal, M.R.; Spitz, P.W.; Williams, C.; Lane, N.E. 1988: Postmarketing surveillance in rheumatology: analysis of purpura and upper abdominal pain Journal of Rheumatology 15(2): 348-355
Faruqui, A.A. 2007: EVOLVE (nebivolol evaluation for efficacy and safety in the treatment of hypertension) postmarketing surveillance study Journal of the Indian Medical Association 105(5): 272; 274; 276-277
Ookubo, H. 2005: Outline of the drug use result survey of Firstcin (cefozopran hydrochloride) as part of postmarketing surveillance in Japan Japanese Journal of Antibiotics 58(5): 469-485
Makino, I.; Nakamura, K.; Sato, Y.; Sato, Y.; Sezai, S.; Ikeda, Y.; Shinmura, W.; Watahiki, H.; Yamamoto, H.; Hioki, Y.; Suzuki, M.; Kumada, T.; Honda, T.; Rikitoku, T.; Hisanaga, Y.; Fukui, H.; Yamao, J.; Kawasaki, H.; Hosoda, A. 2006: Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disorders Current Therapeutic Research 67(1): 1-20
Marzian, O. 2007: Treatment of acute bronchitis in children and adolescents. Non-interventional postmarketing surveillance study confirms the benefit and safety of a syrup made of extracts from thyme and ivy leaves MMW Fortschritte der Medizin 149(27-28 (Suppl): 69-74
Schwarting, J.S. 2000: The pharmaceutical industry--to whom is it accountable? New England Journal of Medicine 343(19): 1416; Discussion 1417
Kahn, M.F. 1984: More on rheumatology and the pharmaceutical industry Journal of Rheumatology 11(5): 717-718
Andersen, K. 1975: The responsibility of the pharmaceutical industry Nordisk Medicin 90(4): 115
Cohen, A.F. 2005: The pharmaceutical industry in uproar Nederlands Tijdschrift Voor Geneeskunde 149(19): 1074
Walker, A.M.; García Rodríguez, L.A.; Pérez Gutthann, S. 1992: Epidemiology and the pharmaceutical industry Medicina Clinica 98(12): 465-468
Aumonier, J. 2003: Action of the pharmaceutical industry Annales Pharmaceutiques Francaises 61(6): 378-382
Gray, C. 1981: The pharmaceutical industry: promoting research in the '80s Canadian Medical Association Journal 124(6): 787-792 Contd